xarelto

Here’s What You Need to Know About Xarelto Lawsuits

xarelto lawsuit information for xarelto induced bleedingExpanded Use of Xarelto was rejected by the FDA three times. In June of 2012, the Food and Drug Administration refused to approve the drug designed as a replacement for older-generation blood thinners like warfarin in patients with acute coronary syndrome (ACS). The agency cited concerns over the manufacturers’, Johnson and Johnson and Bayer, failure to present enough information for them to accurately determine the drug’s potential impacts. The ...

continue reading...

Xarelto Lawsuit Filed in Rhode Island

xarelto lawsuit filed as deaths continue to increaseA Rhode Island man has filed a Xarelto lawsuit against multiple pharmaceutical companies for injuries related to the drug. The plaintiff claimed that the defendants, including Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, received a letter from the FDA in 2013 requesting that they stop improper promotion of their product. The plaintiff further claimed that there is no antidote to the blood-thinning properties of Xarelto, in the event ...

continue reading...

Bayer and Johnson & Johnson Oppose Consolidation of Xarelto Lawsuits

Xarelto plaintiffs are asking that federal lawsuits be consolidated in East St. Louis, IL. Bloomberg reports that there are approximately 50 cases filed in 15 different federal courts to date. The plaintiffs have requested that a multidistrict litigation be formed to help move the cases along more efficiently.

Xarelto is a blood thinner that was first approved for use in 2011. The medication is intended to prevent blood clots in patients undergoing certain ...

continue reading...

Litigation Surrounding Xarelto May Expand to Mass Tort Level in Philadelphia

Lawsuits are being filed over the use of the blood-thinning drug Xarelto and, although it is early in the litigation, lawyers believe there may be a substantial number of cases filed in the future. Some Xarelto lawyers are looking to create a Philadelphia mass tort program for the Xarelto lawsuits as the numbers of cases continues to grow. A recent story in The Legal Intelligencer notes that cases are being filed against a Johnson & Johnson ...

continue reading...

Bayer Begins Facing Xarelto Lawsuits

Bayer facing lawsuits over XareltoBayer AG, a large German pharmaceutical company, is facing its first lawsuits in the United States over its anti-clotting drug Xarelto. A June 14 article reported that there are fewer than 10 Xarelto lawsuits currently filed.

In July 2011, the FDA approved Xarelto to prevent deep vein thrombosis in patients having knee or hip replacement surgery. In November 2012, the drug was approved to prevent pulmonary embolisms. In 2013, Xarelto had ...

continue reading...

FDA panel votes against Xarelto because information missing

A U.S. Food and Drug Administration advisory panel has voted against approving Johnson & Johnson’s blood thinner Xarelto for prevention of blood clots in people with acute coronary syndrome.

According to U.S. News and World Report, the 6-to-4 decision came as a surprise because an FDA briefing document filed Monday in advance of the ruling gave the drug a favorable assessment.

But panel members reportedly said company studies did not provide enough data ...

continue reading...
Page 4 of 5 12345